Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top Correlated Resources
004000.KS
Top 10 Correlated ETFs
004000.KS
Top 10 Correlated Stocks
004000.KS
Financial details
Company Rating
Buy
Market Cap
1433.96B
Income
489.7B
Revenue
2353.3B
Book val./share
86342.72
Cash/share
18568.26
Dividend
2300
Dividend %
4.09%
Employees
850
Optionable
No
Shortable
Yes
Earnings
26 Oct 2022
P/E
2.93
Forward P/E
-
PEG
0.2
P/S
0.61
P/B
0.65
P/C
3.03
P/FCF
3.84
Quick Ratio
1.25
Current Ratio
3.09
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
19.23K
EPS next Y
-
EPS next Q
-
EPS this Y
194.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
45.68%
Revenue last 5Y
8.95%
Revenue Q/Q
5.2%
EPS Q/Q
-1.3%
-
-
-
-
SMA20
-16.14%
SMA50
-9.58%
SMA100
-27.4%
Inst Own
-
Inst Trans
-
ROA
18%
ROE
23%
ROC
0.19%
Gross Margin
22%
Oper. Margin
18%
Profit Margin
21%
Payout
12%
Shs Outstand
25.47M
Shs Float
14.25M
-
-
-
-
Target Price
-
52W Range
54800.0-94500.0
52W High
-40.42%
52W Low
+2.74%
RSI
29
Rel Volume
0.78
Avg Volume
106.8K
Volume
83.12K
Perf Week
-10.49%
Perf Month
-22.02%
Perf Quarter
-34%
Perf Half Y
-32%
-
-
-
-
Beta
0.934847
-
-
Volatility
1949.67%, 5078.33%
Prev Close
0%
Price
56300
Change
1.08%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 45.52K | 53.86K | 51.48K | 49.61K | 69.9K | |
| Net income per share | 3.5K | 8.44K | 6.61K | 7.8K | 22.99K | |
| Operating cash flow per share | 7.41K | 10.73K | 10.11K | 9.94K | 12.11K | |
| Free cash flow per share | 4.95K | 6.94K | 7.31K | 2.97K | 7.72K | |
| Cash per share | 14.05K | 12.47K | 18.01K | 6.3K | 11.82K | |
| Book value per share | 46.83K | 54.1K | 58.62K | 64.77K | 86.32K | |
| Tangible book value per share | 46.24K | 53.09K | 57.68K | 63.87K | 85.52K | |
| Share holders equity per share | 46.83K | 54.1K | 58.62K | 64.77K | 86.32K | |
| Interest debt per share | 11.43K | 3.37K | 3.57K | 782.04 | 895.6 | |
| Market cap | 1935.72B | 1169.07B | 1018.8B | 1385.57B | 1731.96B | |
| Enterprise value | 2085.03B | 1243.42B | 1097.17B | 1395.43B | 1525.6B | |
| P/E ratio | 21.69 | 5.44 | 6.05 | 6.97 | 2.96 | |
| Price to sales ratio | 1.67 | 0.85 | 0.78 | 1.1 | 0.97 | |
| POCF ratio | 10.25 | 4.28 | 3.96 | 5.47 | 5.61 | |
| PFCF ratio | 15.37 | 6.62 | 5.47 | 18.3 | 8.81 | |
| P/B Ratio | 1.62 | 0.85 | 0.68 | 0.84 | 0.79 | |
| PTB ratio | 1.62 | 0.85 | 0.68 | 0.84 | 0.79 | |
| EV to sales | 1.8 | 0.91 | 0.84 | 1.1 | 0.86 | |
| Enterprise value over EBITDA | 10.62 | 3.45 | 3.44 | 3.8 | 1.76 | |
| EV to operating cash flow | 11.04 | 4.55 | 4.26 | 5.51 | 4.94 | |
| EV to free cash flow | 16.55 | 7.04 | 5.89 | 18.43 | 7.76 | |
| Earnings yield | 0.05 | 0.18 | 0.17 | 0.14 | 0.34 | |
| Free cash flow yield | 0.07 | 0.15 | 0.18 | 0.05 | 0.11 | |
| Debt to equity | 0.07 | 0.06 | 0 | 0 | 0 | |
| Debt to assets | 0.27 | 0.19 | 0.17 | 0.12 | 0.19 | |
| Net debt to EBITDA | 0.76 | 0.21 | 0.25 | 0.03 | -0.24 | |
| Current ratio | 1.97 | 3.13 | 3.05 | 3.05 | 2.81 | |
| Interest coverage | 11.11 | 43.76 | 91.08 | 145.12 | 680.64 | |
| Income quality | 2.12 | 1.27 | 1.53 | 1.27 | 0.53 | |
| Dividend Yield | 0 | 0.02 | 0.04 | 0.03 | 0.02 | |
| Payout ratio | 0.09 | 0.09 | 0.26 | 0.22 | 0.07 | |
| Sales general and administrative to revenue | 0.01 | 0 | 0.01 | 0.01 | 0 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | -0.33 | -0.35 | -0.28 | -0.7 | -0.36 | |
| Capex to revenue | -0.05 | -0.07 | -0.05 | -0.14 | -0.06 | |
| Capex to depreciation | -0.83 | -1.19 | -0.77 | -1.66 | -0.93 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 60.76K | 101.35K | 93.38K | 106.65K | 211.29K | |
| ROIC | 0.09 | 0.13 | 0.13 | 0.08 | 0.1 | |
| Return on tangible assets | 0.05 | 0.13 | 0.1 | 0.11 | 0.22 | |
| Graham Net | -836.63 | 3.2K | 9.73K | 466.04 | -3.99K | |
| Working capital | 342.46B | 487.85B | 578.01B | 347.1B | 557.85B | |
| Tangible asset value | 1177.61B | 1352.08B | 1469.01B | 1626.81B | 2178.25B | |
| Net current asset value | 248.43B | 394.23B | 560.96B | 291.91B | 342.04B | |
| Invested capital | 0.24 | 0.06 | 0.06 | 0.01 | 0.01 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 68.49B | 75.57B | 71.9B | 63.74B | 103.95B | |
| Average inventory | 145.55B | 162.24B | 165.13B | 152.45B | 198.48B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 28.16 | 29.77 | 28.43 | 22.6 | 36.77 | |
| Days of inventory on hand | 53.31 | 58.6 | 63.15 | 54.05 | 62.36 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 12.96 | 12.26 | 12.84 | 16.15 | 9.93 | |
| Inventory turnover | 6.85 | 6.23 | 5.78 | 6.75 | 5.85 | |
| ROE | 0.07 | 0.16 | 0.11 | 0.12 | 0.27 | |
| Capex per share | -2.47K | -3.79K | -2.8K | -6.96K | -4.39K |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 16.56K | 19.32K | 20.52K | 25.61K | 26.95K | |
| Net income per share | 4.48K | 8.05K | 8.87K | 1.16K | 1.15K | |
| Operating cash flow per share | 3.53K | 433.34 | 6.5K | 8.77K | 2.12K | |
| Free cash flow per share | 2.13K | -196.3 | 5.51K | 8.13K | 1.24K | |
| Cash per share | 6.85K | 0 | 11.82K | 0 | 18.57K | |
| Book value per share | 69.34K | 77.39K | 86.32K | 85.18K | 86.34K | |
| Tangible book value per share | 68.51K | 77.39K | 85.52K | 85.18K | 85.52K | |
| Share holders equity per share | 69.34K | 77.39K | 86.32K | 85.18K | 86.34K | |
| Interest debt per share | 453.19 | 0 | 885.82 | -5.47K | 658.37 | |
| Market cap | 1681.02B | 2322.86B | 1910.25B | 2017.22B | 1668.06B | |
| Enterprise value | 1679.38B | 2322.86B | 1703.89B | 2017.22B | 1244.05B | |
| P/E ratio | 3.69 | 2.83 | 2.11 | 17.05 | 14.29 | |
| Price to sales ratio | 3.99 | 4.72 | 3.66 | 3.09 | 2.43 | |
| POCF ratio | 18.69 | 210.46 | 11.54 | 9.04 | 30.88 | |
| PFCF ratio | 30.98 | -464.59 | 13.62 | 9.75 | 52.95 | |
| P/B Ratio | 0.95 | 1.18 | 0.87 | 0.93 | 0.76 | |
| PTB ratio | 0.95 | 1.18 | 0.87 | 0.93 | 0.76 | |
| EV to sales | 3.98 | 4.72 | 3.26 | 3.09 | 1.81 | |
| Enterprise value over EBITDA | 9.58 | 7.86 | 5.34 | -27.44 | 17.48 | |
| EV to operating cash flow | 18.67 | 210.46 | 10.3 | 9.04 | 23.03 | |
| EV to free cash flow | 30.95 | -464.59 | 12.15 | 9.75 | 39.49 | |
| Earnings yield | 0.07 | 0.09 | 0.12 | 0.01 | 0.02 | |
| Free cash flow yield | 0.03 | 0 | 0.07 | 0.1 | 0.02 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0.15 | 0.16 | 0.19 | 0.2 | 0.17 | |
| Net debt to EBITDA | -0.01 | 0 | -0.65 | 0 | -5.96 | |
| Current ratio | 2.65 | 3.26 | 2.81 | 2.6 | 3.09 | |
| Interest coverage | 875.68 | 0 | 770.81 | -0.79 | 1.39K | |
| Income quality | 0.79 | 0.05 | 0.73 | 7.55 | 1.85 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0.05 | 0 | 0.04 | 0 | |
| Research and developement to revenue | 0.01 | 0 | 0.01 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0 | 0.01 | 0 | 0.01 | |
| Capex to operating cash flow | -0.4 | -1.45 | -0.15 | -0.07 | -0.42 | |
| Capex to revenue | -0.08 | -0.03 | -0.05 | -0.02 | -0.03 | |
| Capex to depreciation | -1.16 | -0.52 | -0.82 | -0.53 | -0.74 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 83.57K | 118.39K | 131.26K | 47.17K | 47.18K | |
| ROIC | 0.03 | 0.05 | 0.04 | 0.05 | 0.06 | |
| Return on tangible assets | 0.06 | 0.09 | 0.08 | 0.01 | 0.01 | |
| Graham Net | -1.72K | -14.46K | -3.99K | -21.96K | 7.12K | |
| Working capital | 389.51B | 499.28B | 557.85B | 684.94B | 792.96B | |
| Tangible asset value | 1745.05B | 0 | 2178.25B | 0 | 2177.94B | |
| Net current asset value | 319.77B | 352B | 342.04B | 553.09B | 722.46B | |
| Invested capital | 0.01 | 0 | 0.01 | 0 | 0.01 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 34.38 | 0 | 31.75 | 0 | 36.53 | |
| Days of inventory on hand | 45.93 | 0 | 53.85 | 0 | 53.88 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.62 | 0 | 2.83 | 0 | 2.46 | |
| Inventory turnover | 1.96 | 0 | 1.67 | 0 | 1.67 | |
| ROE | 0.06 | 0.1 | 0.1 | 0.01 | 0.01 | |
| Capex per share | -1.4K | -629.64 | -992.46 | -638.28 | -884.31 |
Frequently Asked Questions
What is LOTTE Fine Chemical Co., Ltd. stock symbol ?
LOTTE Fine Chemical Co., Ltd. is a US stock and trading under the symbol 004000.KS
What is LOTTE Fine Chemical Co., Ltd. stock quote today ?
LOTTE Fine Chemical Co., Ltd. stock price is $56300 today.
Is LOTTE Fine Chemical Co., Ltd. stock public?
Yes, LOTTE Fine Chemical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 106.8K
- Market Capitalization 1433.96B
- Employee 850
- Headquarters Ulsan,US
- IPO Date 2000-01-04
-
Website
https://www.lottefinechem.com 
LOTTE Fine Chemical Co., Ltd. manufactures and sells chemical products in Korea. It offers cellulose relatives, including MECELLOSE, hydroxyethyl cellulose, AnyCoat-C (hypromellose), and AnyCoat-P (hypromellose phthalate) for use in various fields, such as construction, cement extrusion, ceramic extrusion, paint, medicine, and household items. The company also provides epichlorohydrin, caustic soda, methyl and methylene chloride, chloroform, sodium hypochlorite, methaclean, hydrochloric acid, and PTAC for use in architecture, textiles, and resins industries. In addition, it offers general chemicals, which include EUROX, ammonia, ammonium hydroxide, monomethyl amine, dimethylamine, trimethylamine, and trimethylamine-HCl; tetramethyl ammonium hydroxide, a material for semiconductor; and polymerized toners for color laser printers. The company was formerly known as SAMSUNG Fine Chemicals Co., Ltd. changed its name to LOTTE Fine Chemical Co., Ltd. in 2016. LOTTE Fine Chemical Co., Ltd. was founded in 1964 and is headquartered in Ulsan, South Korea.
